참고문헌 (38)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 3143 3421 12485966 

   상세보기

2. Franceschini G Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease Am J Cardiol 2001 88 12 9N 13N 10.1016/S0002-9149(01)02146-4 11788124 

   상세보기

3. Gomaraschi M Baldassarre D Amato M Eligini S Conca P Sirtori CR Franceschini G Calabresi L Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I (Milano) mutant Circulation 2007 116 2165 2172 10.1161/CIRCULATIONAHA.107.705657 17967773 

   상세보기

4. Barter PJ Caulfield M Eriksson M Grundy SM Kastelein JJP Komajda M Sendon JL Mosca L Tardif JC Waters DD Shear CL Revkin JH Buhr KA Fisher MR Tall AR Brewer B Effects of Torcetrapib in Patients at High Risk for Coronary Events N Engl J Med 2007 357 2109 2122 10.1056/NEJMoa0706628 17984165 

   상세보기

5. Hausenloy DJ Yellon DM Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Postgrad Med J 2008 84 997 590 598 19103817 

   상세보기

6. Yamashita S Matsuzawa Y Where are we with probucol: a new life for an old drug? Atherosclerosis 2009 207 1 16 23 10.1016/j.atherosclerosis.2009.04.002 19457483 

   상세보기

7. Tardif JC Cote G Lesperance J Bourassa M Lambert J Doucet S Bilodeau L Nattel S Guise P Probucol and multivitamins in the prevention of restenosis after coronary angioplasty N Engl J Med 1997 337 365 732 10.1056/NEJM199708073370601 9241125 

   상세보기

8. Yamashita S Hbujo H Arai H Harada-Shiba M Matsui S Fukushima M Saito Y Kita T Matsuzawa Y Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan J Atheroscler Thromb 2008 15 6 292 303 10.5551/jat.E610 19060422 

   상세보기

9. Hazen S HDL structure, function, therapeutics, and imaging Arterioscler Thromb Vasc Biol 2010 30 2 138 10.1161/ATVBAHA.109.201897 20089949 

   상세보기

10. Tsompanidi EM Brinkmeier MS Fotiadou EH Giakoumi SM Kypreos KE HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis Atherosclerosis 2010 208 1 3 9 10.1016/j.atherosclerosis.2009.05.034 19595353 

    상세보기

11. Vekic J Kotur-Stevuljevic J Jelic-Ivanovic Z Spasic S Spasojevic-Kalimanovska V Topic A Zeljkovic A Stefanovic A Zunic G Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects Eur J Clin Invest 2007 37 9 715 723 10.1111/j.1365-2362.2007.01849.x 17696961 

    상세보기

12. Heinecke JW The role of myeloperoxidase in HDL oxidation and atherogenesis Curr Atheroscler Rep 2007 9 4 249 251 10.1007/s11883-007-0027-2 18173946 

    상세보기

13. Duffy D Rader DJ Update on strategies to increase HDL quantity and function Nat Rev Cardiol 2009 6 7 455 463 10.1038/nrcardio.2009.94 19488077 

    상세보기

14. Movva R Rader DJ Laboratory assessment of HDL heterogeneity and function Ann Biol Clin (Paris) 2009 67 1 7 21 

15. Kontush A Chapman MJ Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol Rev 2006 58 3 342 374 10.1124/pr.58.3.1 16968945 

    상세보기

16. Movva R Rader DJ Laboratory assessment of HDL heterogeneity and function Ann Biol Clin (Paris) 2009 67 1 7 21 

17. Hiroshi N Latest Insights into High Density Lipoprotein Functions The Endocrinologist 2009 19 4 179 186 10.1097/TEN.0b013e3181a6a5ed 

    상세보기

18. Orsó E Broccardo C Kaminski WE Böttcher A Liebisch G Drobnik W Götz A Chambenoit O Diederich W Langmann T Spruss T Luciani MF Rothe G Lackner KJ Chimini G Schmitz G Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice Nat Genet 2000 24 2 192 196 10.1038/72869 10655069 

    상세보기

19. Neufeld EB Stonik JA Demosky SJ Jr Knapper CL Combs CA Cooney A Comly M Dwyer N Blanchette-Mackie J Remaley AT Santamarina-Fojo S Brewer HB Jr The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease J Biol Chem 2004 279 15 15571 15578 10.1074/jbc.M314160200 14747463 

    상세보기

20. Cavelier LB Qiu Y Bielicki JK Afzal V Cheng JF Rubin EM Regulation and activity of the human ABCA1 gene in transgenic mice J Biol Chem 2001 276 21 18046 18051 10.1074/jbc.M100565200 11279093 

    상세보기

21. Zannis VI Chroni A Krieger M Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL J Mol Med 2006 84 4 276 294 10.1007/s00109-005-0030-4 16501936 

    상세보기

22. Liadaki KN Liu T Xu S Ishida BY Duchateaux PN Krieger JP Kane J Krieger M Zannis VI Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding J Biol Chem 2000 275 28 21262 21271 10.1074/jbc.M002310200 10801839 

    상세보기

23. Rigotti A Trigatti BL Penman M Rayburn H Herz J Krieger M A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism Proc Natl Acad Sci USA 1997 94 23 12610 12615 10.1073/pnas.94.23.12610 9356497 

    상세보기

24. Out R Hoekstra M Spijkers JA Kruijt JK van Eck M Bos IS Twisk J Van Berkel TJ Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice J Lipid Res 2004 45 11 2088 2095 10.1194/jlr.M400191-JLR200 15314100 

    상세보기

25. Mackness MI Durrington PN HDL, its enzymes and its potential to influence lipid peroxidation Atherosclerosis 1995 115 2 243 253 10.1016/0021-9150(94)05524-M 7661883 

    상세보기

26. Kontush A Chantepie S Chapman MJ Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress Arterioscler Thromb Vasc Biol 2003 23 10 1881 1888 10.1161/01.ATV.0000091338.93223.E8 12920049 

    상세보기

27. Mackness B Durrington PN Boulton AJ Hine D Mackness MI Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls Eur J Clin Invest 2002 32 4 259 264 10.1046/j.1365-2362.2002.00977.x 11952811 

    상세보기

28. Navab M Hama-Levy S Van Lenten BJ Fonarow GC Cardinez CJ Castellani LW Brennan ML Lusis AJ Fogelman AM La Du BN Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio J Clin Invest 1997 99 8 2005 2019 10.1172/JCI119369 9109446 

    상세보기

29. Rye KA Clay MA Barter PJ Remodelling of high density lipoproteins by plasma factors Atherosclerosis 1999 145 2 227 238 10.1016/S0021-9150(99)00150-1 10488948 

    상세보기

30. K Nicholls SJ Zheng L Hazen SL Formation of dysfunctional high-density lipoprotein by myeloperoxidase Trends Cardiovasc Med 2005 15 6 212 219 10.1016/j.tcm.2005.06.004 16182131 

    상세보기

31. Niu X Zammit V Upston JM Dean RT Stocker R Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques Arterioscler Thromb Vasc Biol 1999 19 7 1708 1718 10.1161/01.ATV.19.7.1708 10397689 

    상세보기

32. Zheng L Nukuna B Brennan ML Sun M Goormastic M Settle M Schmitt D Fu X Thomson L Fox PL Ischiropoulos H Smith JD Kinter M Hazen SL Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J Clin Invest 2004 114 4 529 541 15314690 

    상세보기

33. Beltowski J Jamroz-Wisniewska A Borkowska E Wójcicka G Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats Pharmacol Res 2005 51 6 523 532 10.1016/j.phrs.2005.01.007 15829432 

    상세보기

34. Zhao SP Yang J Li J Dong SZ Wu ZH Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits Int J Cardiol 2008 124 2 172 178 10.1016/j.ijcard.2006.12.032 17395297 

    상세보기

35. Troutt JS Alborn WE Mosior MK Dai J Murphy AT Beyer TP Zhang Y Cao G Konrad RJ An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma J Lipid Res 2008 49 3 581 587 10.1194/jlr.M700385-JLR200 18056684 

    상세보기

36. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609 

    상세보기

37. Pirillo A Uboldi P Kuhn H Catapano AL 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages Biochim Biophys Acta 2006 1761 3 292 300 10.1016/j.bbalip.2006.03.009 16647293 

    상세보기

38. Speidl WS Cimmino G Ibanez B Elmariah S Hutter R Garcia MJ Fuster V Goldman ME Badimon JJ Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model Eur Heart J 2010 31 16 2049 2057 20304838 

    상세보기